Heartseed
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
2
Funding Rounds
$63.0m
Money raised
Overview
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
- Websites:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Heartseed has raised a total of $63m in funding over 2 rounds.
Key Insights:
- Heartseed Series C round, June 2021: $37m
- Heartseed Series B round, November 2019: $26m
Heartseed Series C round, June 2021
$37m
Heartseed Series B round, November 2019
$26m
Industries
Heartseed is active in the following industries: